MacroGenics Total Assets 2012-2019 | MGNX

MacroGenics total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
MacroGenics Annual Total Assets
(Millions of US $)
2018 $332
2017 $374
2016 $311
2015 $359
2014 $174
2013 $126
2012 $54
2011 $63
MacroGenics Quarterly Total Assets
(Millions of US $)
Q2 2019 $384
Q1 2019 $415
Q4 2018 $332
Q3 2018 $355
Q2 2018 $387
Q1 2018 $326
Q4 2017 $374
Q3 2017 $242
Q2 2017 $275
Q1 2017 $275
Q4 2016 $311
Q3 2016 $340
Q2 2016 $369
Q1 2016 $326
Q4 2015 $359
Q3 2015 $384
Q2 2015 $254
Q1 2015 $278
Q4 2014 $174
Q3 2014 $194
Q2 2014 $206
Q1 2014 $210
Q4 2013 $126
Q3 2013 $42
Q2 2013 $42
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q2 2012 $0
Q4 2011 $63
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.562B $0.060B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.155B 20.38
Abbott Laboratories (ABT) United States $144.891B 27.24
Stryker (SYK) United States $80.414B 27.81
Boston Scientific (BSX) United States $53.574B 25.99
Baxter (BAX) United States $44.796B 27.16
EssilorLuxottica Societe Anonyme (ESLOY) France $32.784B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.311B 18.12
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.166B 0.00
Terumo (TRUMY) Japan $23.897B 29.82
Smith & Nephew SNATS (SNN) United Kingdom $20.556B 0.00
ResMed (RMD) United States $18.755B 35.74
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.968B 53.44
Insulet (PODD) United States $9.367B 555.07
Perrigo (PRGO) Ireland $7.321B 13.49
Canopy Growth (CGC) Canada $6.992B 0.00
Hill-Rom Holdings (HRC) United States $6.758B 20.15
Haemonetics (HAE) United States $6.423B 48.47
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.717B 0.00
Neogen (NEOG) United States $3.401B 56.90
NuVasive (NUVA) United States $3.312B 26.40
ICU Medical (ICUI) United States $3.149B 20.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.522B 0.00
Quidel (QDEL) United States $2.431B 24.14
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
National Vision Holdings (EYE) United States $1.919B 41.42
Cardiovascular Systems (CSII) United States $1.617B 0.00
Aphria (APHA) $1.368B 0.00
VAREX IMAGING (VREX) United States $1.117B 25.74
AtriCure (ATRC) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.885B 14.39
Eagle Pharmaceuticals (EGRX) United States $0.847B 21.60
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.778B 18.37
Omeros (OMER) United States $0.764B 0.00
Lantheus Holdings (LNTH) United States $0.742B 19.50
LeMaitre Vascular (LMAT) United States $0.670B 39.72
Cerus (CERS) United States $0.633B 0.00
Surmodics (SRDX) United States $0.607B 115.31
Quanterix (QTRX) United States $0.554B 0.00
OraSure Technologies (OSUR) United States $0.510B 23.60
TG Therapeutics (TGTX) United States $0.507B 0.00
Meridian Bioscience (VIVO) United States $0.423B 13.21
Owens & Minor (OMI) United States $0.406B 12.17
Zynex (ZYXI) United States $0.384B 40.79
Utah Medical Products (UTMD) United States $0.342B 25.05
BioLife Solutions (BLFS) United States $0.329B 101.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.321B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.179B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.148B 0.00
Female Health (VERU) United States $0.137B 0.00
Fonar (FONR) United States $0.131B 9.16
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
Chimerix (CMRX) United States $0.088B 0.00
United-Guardian (UG) United States $0.086B 20.46
Nephros (NEPH) United States $0.077B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00